These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24410324)

  • 1. Gender moderates the influence of psychosocial factors and drug use on HAART adherence in the context of HIV and childhood sexual abuse.
    Wilson SM; Sikkema KJ; Ranby KW
    AIDS Care; 2014; 26(8):959-67. PubMed ID: 24410324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.
    Dale S; Cohen M; Weber K; Cruise R; Kelso G; Brody L
    AIDS Patient Care STDS; 2014 Mar; 28(3):136-43. PubMed ID: 24568654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.
    Applebaum AJ; Richardson MA; Brady SM; Brief DJ; Keane TM
    AIDS Behav; 2009 Feb; 13(1):60-5. PubMed ID: 18690532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to HIV Medication Adherence: Examining Distinct Anxiety and Depression Symptoms among Women Living with HIV Who Experienced Childhood Sexual Abuse.
    Willie TC; Overstreet NM; Sullivan TP; Sikkema KJ; Hansen NB
    Behav Med; 2016; 42(2):120-7. PubMed ID: 26010763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender Disparities in Traumatic Life Experiences and Antiretroviral Therapy Adherence Among People Living with HIV in South Carolina.
    Brown MJ; Harrison SE; Li X
    AIDS Behav; 2019 Nov; 23(11):2904-2915. PubMed ID: 30798459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.
    Nakimuli-Mpungu E; Mutamba B; Othengo M; Musisi S
    Afr Health Sci; 2009 Aug; 9 Suppl 1(Suppl 1):S2-7. PubMed ID: 20589156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.
    Mimiaga MJ; Safren SA; Dvoryak S; Reisner SL; Needle R; Woody G
    AIDS Care; 2010 Nov; 22(11):1305-13. PubMed ID: 20640954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians.
    Malow R; Dévieux JG; Stein JA; Rosenberg R; Jean-Gilles M; Attonito J; Koenig SP; Raviola G; Sévère P; Pape JW
    AIDS Behav; 2013 May; 17(4):1221-30. PubMed ID: 23338563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. People with HIV in HAART-era Russia: transmission risk behavior prevalence, antiretroviral medication-taking, and psychosocial distress.
    Amirkhanian YA; Kelly JA; Kuznetsova AV; DiFranceisco WJ; Musatov VB; Pirogov DG
    AIDS Behav; 2011 May; 15(4):767-77. PubMed ID: 20803063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the relationship between adherence to Highly Active Antiretroviral Therapy (HAART) and social and clinical characteristics in Chinese patients with HIV.
    Wang YY; Wang T; Yan H; D'Amato RC; Wang W; Li SY
    AIDS Care; 2019 Jan; 31(1):14-18. PubMed ID: 30430839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's perspectives on ImpACT: a coping intervention to address sexual trauma and improve HIV care engagement in Cape Town, South Africa.
    Knettel BA; Mulawa MI; Knippler ET; Ciya N; Robertson C; Joska JA; Sikkema KJ
    AIDS Care; 2019 Nov; 31(11):1389-1396. PubMed ID: 30821168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV.
    Royal SW; Kidder DP; Patrabansh S; Wolitski RJ; Holtgrave DR; Aidala A; Pals S; Stall R
    AIDS Care; 2009 Apr; 21(4):448-55. PubMed ID: 19401865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-Infected patients in a population-based cohort.
    Kuyper LM; Wood E; Montaner JS; Yip B; O'connell JM; Hogg RS
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1470-6. PubMed ID: 15602125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood Sexual Trauma and Antiretroviral Therapy Adherence: A Mixed-Methods Systematic Review.
    Brown MJ; Brown AD; Haider MR; Edwards A; Crouch E; Li X
    AIDS Behav; 2021 Feb; 25(2):475-491. PubMed ID: 32844336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART).
    Purohit V; Rapaka RS; Schnur P; Shurtleff D
    Life Sci; 2011 May; 88(21-22):909-16. PubMed ID: 21477599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
    Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G
    Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Damaging what wasn't damaged already": psychological tension and antiretroviral adherence among HIV-infected methadone-maintained drug users.
    Batchelder AW; Brisbane M; Litwin AH; Nahvi S; Berg KM; Arnsten JH
    AIDS Care; 2013; 25(11):1370-4. PubMed ID: 23406479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.